Winstock AR

Global Drug Survey, London, UK.

9 papers · ORCID

ArticleKetamine

Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment.

Barrios KP, Connolly DJ, Ferris JA +5

Europe PMC2025
ArticleMDMA

The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study.

Coney L, Peacock A, Malm A +6

Europe PMC2024
ArticlePsilocybin

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.

Kopra EI, Ferris JA, Winstock AR +3

Europe PMC2023
ArticleLSD

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD).

Kopra EI, Ferris JA, Rucker JJ +4

Europe PMC2022
ArticlePsilocybin

Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.

Kopra EI, Ferris JA, Winstock AR +2

Europe PMC2022
ArticlePsilocybin

Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.

Petranker R, Anderson T, Maier LJ +3

Europe PMC2022
ArticleAyahuasca

Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.

Lawn W, Hallak JE, Crippa JA +6

Europe PMC2017
ArticleDMT

Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.

Palamar JJ, Barratt MJ, Ferris JA +1

Europe PMC2016
ArticleDMT

Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.

Winstock AR, Kaar S, Borschmann R

Europe PMC2014